About Petra Van Vlierberghe
Form D filings for OncoVerity from 2022 to 2024 list Petra Van Vlierberghe as director.
Petra Van Vlierberghe first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Petra Van Vlierberghe in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Petra Van Vlierberghe works with at each company, as listed on that company's latest Form D.
OncoVerity, Inc. · Form D, Dec 10, 2024
MC
Massimiliano Colao
Chief Executive Officer and director
AL
Arjen Lemmen
Director
KM
Kimberly Muller
Director
SH
Steven Hess
Director
CS
Clayton Smith
Chief Medical Officer